Displaying 1 - 10 of 154

Financial Press

Delisting of shares from Nasdaq Stockholm

2021.02.19 Read more

Financial Press

Notice of extraordinary general meeting in Recipharm AB (publ)

2021.02.16 Read more

Financial Press

Recipharm applies for delisting of shares and summons to extraordinary general meeting

2021.02.15 Read more

Financial Press

Results of meeting of the holders of Recipharm convertible bonds: consent granted to correct error in terms and conditions

2021.02.03 Read more

Financial Press

Statement by the Board of Directors of Recipharm regarding the public offer from Roar BidCo

2021.01.28 Read more

Financial Press

Recipharm has convened a bondholder meeting to correct the terms and conditions of its convertible bonds and announces date for a preliminary 2020 year-end report

2021.01.11 Read more

Financial Press

Announcement of consent solicitation by Recipharm AB (publ) in respect of its SEK 1,000,000,000 Senior Unsecured Convertible Bonds due 2021 (ISIN: XS1496895753)

2021.01.11 Read more

Financial Press

Recipharm and Moderna finalize agreement for aseptic drug product manufacturing and fill-finish for supply to countries outside the U.S.

2020.12.30 Read more

Financial Press

Comment from Recipharm’s board of directors regarding the public offer from Roar BidCo and correction of error in convertible bond terms

2020.12.14 Read more

Financial Press

Recipharm announces signature of letter of intent for aseptic fill-finish manufacturing of Moderna’s COVID-19 vaccine candidate (mRNA-1273)

2020.11.24 Read more